Stock Price Quote

AUROBINDO PHARMA LTD.

NSE : AUROPHARMABSE : 524804ISIN CODE : INE406A01037Industry : Pharmaceuticals & DrugsHouse : Aurobindo
BSE540.80-18.05 (-3.23 %)
PREV CLOSE ( ) 558.85
OPEN PRICE ( ) 559.95
BID PRICE (QTY) 540.80 (349)
OFFER PRICE (QTY) 541.10 (84)
VOLUME 63398
TODAY'S LOW / HIGH ( )540.80 559.95
52 WK LOW / HIGH ( )521 1043
NSE543.35-15.45 (-2.76 %)
PREV CLOSE( ) 558.80
OPEN PRICE ( ) 557.95
BID PRICE (QTY) 543.15 (103)
OFFER PRICE (QTY) 543.35 (148)
VOLUME 977792
TODAY'S LOW / HIGH( ) 542.00 557.95
52 WK LOW / HIGH ( )520.85 1043.1
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 26-12 1986
Management Info
K Ragunathan - Chairman - Managing Director
Registered Office

Address Plot No. 2,Maitrivihar ,Ameerpet,
Hyderabad,
Telangana-500038

Phone 040-23736370/23747340

Email info@aurobindo.com

Website www.aurobindo.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX

NEWS

12May Completion Of US FDA Inspection At Ou
Sub: Completion of US FDA Inspection at our Unit VII - Reg., Pursuan..
11May Aurobindo Pharma gets 6 observations f
The United States Food and Drug Administration (US FDA) has inspected Au..
04May Aurobindo Pharma’s arm gets USFDA appr
Aurobindo Pharma’s wholly owned subsidiary company -- Eugia Pharma Speci..
04May Announcement under Regulation 30 (LOD
We enclose a copy of the Press Release that is being issued by the Compa..
25Apr Aurobindo Pharma’s unit recalls Cyanoc
Aurobindo Pharma’s unit -- Aurobindo Pharma USA Inc is recalling Cyanoco..

Financials

in Millions
QTR Dec 21 ANNUAL 21
Net Profit2398.131129.1
Gross Profit 2424.6 41930.1
Operating Profit 347247096.8
Net Sales 26230.5158236.8

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Dr. Reddy's Lab (BSE)
peergroup  4347.60 (1.72%)
M.Cap ( in Cr)72330.34
Shilpa Medicare (BSE)
peergroup  449.85 (9.64%)
M.Cap ( in Cr)3983.34
Hikal (BSE)
peergroup  400.30 (9.01%)
M.Cap ( in Cr)4906.14
Kwality Pharma (BSE)
peergroup  417.10 (5.00%)
M.Cap ( in Cr)432.79
Hester Biosciences (BSE)
peergroup  2246.10 (0.60%)
M.Cap ( in Cr)1926.76

Shareholding Pattern

NON-INSTITUTION 9.86%
PROMOTERS 51.83%
FI/BANKS/INSURANCE 5.73%
MUTUAL FUNDS/UTI 10.09%
GOVERNMENT 0%
FII 0%

About Aurobindo Pharma Ltd.

Aurobindo Pharma Ltd. was incorporated in the year 1986. Its today's share price is 540.8. Its current market capitalisation stands at Rs 32059.63 Cr. In the latest quarter, company has reported Gross Sales of Rs. 158758.2 Cr and Total Income of Rs.164135.4 Cr. The company's management includes B Adi Reddy, Girish Paman Vanvari, Savita Mahajan, Avnit Bimal Singh, PV Ramprasad Reddy, P Sarath Chandra Reddy, M Madan Mohan Reddy, M Sivakumaran, K Nithyananda Reddy, K Ragunathan.

It is listed on the BSE with a BSE Code of 524804 , NSE with an NSE Symbol of AUROPHARMA and ISIN of INE406A01037. It's Registered office is at Plot No. 2,Maitrivihar ,AmeerpetHyderabad-500038, Telangana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BSR & Associates LLP, K Nagaraju & Associates, SR Batliboi & Associates, SR Batliboi & Associates LLP, SR Batliboi & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)